SLONIN JONATHAN 4
4 · Pacira BioSciences, Inc. · Filed Jul 3, 2024
Insider Transaction Report
Form 4
SLONIN JONATHAN
Chief Medical Officer
Transactions
- Award
Common Stock
2024-06-28$24.32/sh+437.271$10,634→ 99,306.746 total - Tax Payment
Common Stock
2024-07-01$28.46/sh−914$26,012→ 98,392.746 total - Sale
Common Stock
2024-07-02$28.25/sh−2,836$80,117→ 95,556.746 total
Footnotes (3)
- [F1]Represents shares of common stock acquired under the issuer's employee stock purchase plan in June 2024.
- [F2]Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award.
- [F3]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.